<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05020691</url>
  </required_header>
  <id_info>
    <org_study_id>298787</org_study_id>
    <nct_id>NCT05020691</nct_id>
  </id_info>
  <brief_title>NIV in Covid-19 Respiratory Failure</brief_title>
  <official_title>Non-invasive Ventilation in Covid-19 Respiratory Failure - Predicting Success: A Retrospective Observational Study to Determine Predictive Factors in the Success or Failure of Non-invasive Ventilation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heatlh Service Ayrshire and Arran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heatlh Service Ayrshire and Arran</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective, single centre observational study to validate use of the HACOR score (Duan&#xD;
      et al, 2017) in determining efficacy of non-invasive ventilation in Covid-19 respiratory&#xD;
      failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will retrospectively analyse medical records of patients with confirmed&#xD;
      Covid-19 respiratory failure who received continuous positive airway pressure (CPAP) via&#xD;
      facemask, as per clinician decision, in the High Dependency Unit (HDU) or Intensive Care Unit&#xD;
      (ICU) of University Hospital Crosshouse between 1st March 2020 and 30th April 2021. By&#xD;
      collecting baseline demographics and physiological data (including APACHE II and clinical&#xD;
      frailty score) and calculating the HACOR score at initiation of CPAP, then at 1hr, 6hrs,&#xD;
      12hrs, 24hrs and 48hrs after initiating CPAP the investigators aim to validate use of the&#xD;
      HACOR score in determining efficacy of NIV in Covid-19 respiratory failure. The investigators&#xD;
      will also collect other variables (CRP and lymphocytes, lactate, mean arterial pressure,&#xD;
      temperature) to determine if these factors have utility in predicting efficacy of NIV in&#xD;
      Covid-19 respiratory failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Availability of research team limited by clinical workload (COVID-19)&#xD;
  </why_stopped>
  <start_date type="Actual">August 18, 2021</start_date>
  <completion_date type="Actual">November 3, 2021</completion_date>
  <primary_completion_date type="Actual">November 3, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Escalation to Invasive Ventilation</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Number of patients who deteriorated after NIV commenced, requiring escalation to invasive ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Death Due to Respiratory Failure</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Number of patients who deteriorated after NIV commenced, resulting in death due to respiratory failure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Improvement</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Number of patients who improved after NIV commenced, resulting in liberation from NIV (without requiring invasive ventilation)</description>
  </primary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>COVID-19 Pneumonia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with confirmed Covid-19 respiratory failure treated with facemask CPAP in a&#xD;
        district general hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Confirmed Covid-19 respiratory failure&#xD;
&#xD;
          2. NIV treatment instituted as per clinician decision&#xD;
&#xD;
          3. Admitted to HDU or ICU between 1/3/20 and 30/4/21&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with immediate indication for invasive ventilation&#xD;
&#xD;
          2. Patients whose primary diagnosis was not Covid-19 respiratory failure, but received&#xD;
             NIV in that time period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Crosshouse</name>
      <address>
        <city>Kilmarnock</city>
        <zip>KA2 0BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017 Feb;43(2):192-199. doi: 10.1007/s00134-016-4601-3. Epub 2016 Nov 3.</citation>
    <PMID>27812731</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Heatlh Service Ayrshire and Arran</investigator_affiliation>
    <investigator_full_name>Jamie Hooker</investigator_full_name>
    <investigator_title>Senior Clinical Fellow, Intensive Care</investigator_title>
  </responsible_party>
  <keyword>Covid-19</keyword>
  <keyword>HACOR</keyword>
  <keyword>Non-Invasive Ventilation</keyword>
  <keyword>CPAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

